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Abstract
Background: Particulate air pollution has been associated with cardiovascular morbidity and mortality, but it
remains unclear which time windows and pollutant sources are most critical. MicroRNA (miRNA) is thought to be
involved in cardiovascular regulation. However, little is known about whether polymorphisms in genes that process
microRNAs influence response to pollutant exposure. We hypothesized that averaging times longer than routinely
measured one or two day moving averages are associated with higher soluble intercellular adhesion molecule-1
(sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) levels, and that stationary and mobile sources
contribute differently to these effects. We also investigated whether single nucleotide polymorphisms (SNPs) in
miRNA-processing genes modify these associations.
Methods: sICAM-1 and sVCAM-1 were measured from 1999-2008 and matched to air pollution monitoring for fine
particulate matter (PM2.5) black carbon, and sulfates (SO4
2-). We selected 17 SNPs in five miRNA-processing genes.
Mixed-effects models were used to assess effects of pollutants, SNPs, and interactions under recessive inheritance
models using repeated measures.
Results: 723 participants with 1652 observations and 1-5 visits were included in our analyses for black carbon and
PM2.5. Sulfate data was available for 672 participants with 1390 observations. An interquartile range change in
seven day moving average of PM2.5 (4.27 μg/m
3) was associated with 3.1% (95%CI: 1.6, 4.6) and 2.5% (95%CI: 0.6,
4.5) higher sICAM-1 and sVCAM-1. Interquartile range changes in sulfates (1.39 μg/m3) were associated with 1.4%
higher (95%CI: 0.04, 2.7) and 1.6% (95%CI: -0.4, 3.7) higher sICAM-1 and sVCAM-1 respectively. No significant
associations were observed for black carbon. In interaction models with PM2.5, both sICAM-1 and sVCAM-1 levels
were lower in rs1062923 homozygous carriers. These interactions remained significant after multiple comparisons
adjustment.
Conclusions: PM2.5 seven day moving averages are associated with higher sICAM-1 and sVCAM-1 levels. SO4
-2
seven day moving averages are associated with higher sICAM-1 and a suggestive association was observed with
sVCAM-1 in aging men. SNPs in miRNA-processing genes may modify associations between ambient pollution and
sICAM-1 and sVCAM-1, which are correlates of atherosclerosis and cardiovascular disease.
Background
Particulate air pollution has been associated with cardio-
vascular morbidity and mortality, but the underlying
mechanisms are not well understood. Blood markers
such as intercellular adhesion molecule-1 (ICAM-1) and
vascular cell adhesion molecule-1 (VCAM-1), which are
expressed on cell surfaces, are markers of inflammation
and endothelial function found in soluble form (sICAM-
1 and sVCAM-1) within the serum [1]. Short-term
exposures to particulate air pollution have been asso-
ciated with higher levels of these biomarkers within
populations of susceptible individuals such as asthmatic
children [2], diabetics [3], and men with coronary heart
disease [4], but it is not known which time windows are
most pertinent and what components and sources of
pollution may be most toxic. Most studies have
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examined acute effects in the 24 to 48 hour range, but
longer averaging times of approximately one week may
be more relevant to understanding the associations
between particles and cardiovascular function and pro-
cesses [3,5-8]. It has also been hypothesized that pollu-
tant sources such as traffic or coal-burning power plants
contribute differently in their associations with health
effects and biomarker levels, but data remain limited.
Genetic and epigenetic changes have been shown to
influence individual-level responses to ambient pollution
for a wide variety of cardiovascular effects [9-11]. Stu-
dies have shown that polymorphisms in genes related to
oxidative stress may alter susceptibility to air pollution
as measured by biomarkers of endothelial and vascular
function [12-16]. Interest is growing in the examination
of epigenetic changes, which refer to modification of
genes that are not due to changes in the DNA itself.
Widely studied epigenetic marks including DNA methy-
lation and histone modification have been associated
with changes in disease status, most notably with cancer
[17], but also with heart failure [18] and coronary artery
disease [11,19]. Recently, epigenetic marks have also
been shown to be modified in the presence of environ-
mental factors such as traffic [20] and benzene exposure
[21]. Additionally, changes in gene-specific and global
DNA methylation have been observed in response to
prenatal smoking exposures [22].
We recently examined associations between blood
pressure and interactions between black carbon and Sin-
gle Nucleotide Polymorphisms (SNPs) in microRNA
(miRNA) processing genes and observed evidence of
effect modification [23], but this area of research
remains relatively unexplored. miRNAS are small non-
coding RNAs that repress or inhibit gene expression by
targeting messenger RNA (mRNA) [24,25]. It is thought
that miRNAs play a role in a number of pathogenic
pathways including angiogenesis [26], inflammation [27],
redox signaling [28], and stress response [29]. miRNA
mediation of cardiovascular disease is of interest due to
recognition that dysregulation of cell-signaling pathways
associated with miRNA is a key factor affecting heart
disease [24,30-33]. A few studies in controlled environ-
ments have also observed cardiovascular effects due to
loss of function of miRNA processing genes [34-36].
While a number of miRNAs may target numerous
genes, the processing of miRNAs to maturity is regu-
lated by a relatively small set of genes.
For this study, we investigated whether longer aver-
aging times of particulate air pollution (PM2.5) seven
days for fine particulate air pollution (PM2.5) were asso-
ciated with higher levels of adhesion molecules. We also
investigated whether specific sources of particles from
mobile sources, represented by black carbon (BC), and
sulfates (SO4
2), a surrogate for fossil-fuel burning power
plants, were differentially associated with these effects,
and whether those effects were modified by SNPs in
miRNA-processing genes.
Methods
Study Population
Study participants were members of the Veterans
Administration Normative Aging Study. This is an
ongoing longitudinal study of aging established in 1963,
details of which have been published previously [37].
Briefly, the Normative Aging Study began as a closed
cohort of male volunteers from the Greater Boston area
aged 21 to 80 at entry, who enrolled after an initial
health screening determined that they were free of
known chronic medical conditions. All participants pro-
vided written informed consent and the study was
approved by all participating institutions. Participants
return to the study center for examination every three
to five years. By 1999, when measurements of sICAM-1
and sVCAM-1 began, 668 original participants had died
and a number subjects were no longer being followed,
the majority because they moved out of the region fol-
lowing retirement. A total of 817 participants were still
returning for regular examinations on a three to five
year schedule. Among these participants, 811 (99.3%)
were measured for sVCAM-1 and sICAM-1 in at least
one visit. Of the 811 participants with cellular adhesion
molecule measurements between 1999 and 2008, we
restricted to the 784 of participants who reported their
race as white. We chose to restrict to individuals of
white race due to the very small numbers of study parti-
cipants who reported being of other races (4%) and to
limit the potential for population stratification.
sICAM-1 and sVCAM-1 measurements
sICAM-1 and sVCAM-1 were measured in the serum
during medical exam visits from 1999 through 2008 by
ELISA assay (R & D Systems, Minneapolis, MN), with a
sensitivity of 0.35 ng/mL for sICAM-1 and 2.0 ng/mL
for sVCAM-1.
SNP Selection and Genotyping
SNPs were selected based on previously published work
investigating associations between genes involved in
miRNA processing and disease [38,39]. These SNPs were
chosen because of overlap in pathways involved in pro-
cesses related to autonomic function through cell signal-
ing, apoptosis, angiogenesis and inflammation. Although
miRNAs regulate many cellular processes, often targeting
multiple genes, the processing of miRNAs to maturity is
thought to be controlled by a smaller subset of genes.
We selected five of these genes, which have been shown
to be key regulators of miRNA processing GEMIN3,
GEMIN4, DROSHA, DICER and DGCR8 [40,41].
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Genotyping was performed using multiplex PCR
assays designed with Sequenom SpectroDESIGNER soft-
ware. The extension product was then spotted onto a
384 well spectroCHIP before analysis in the MALDI-
TOF mass spectrometer. Duplication was performed on
5% of the samples. We examined associations with 17
SNPs for this analysis, all of which were successfully
genotyped in the majority of study participants. Three
SNPs were removed because fewer than 10 participants
were homozygous carriers. This left a total of 14 SNPs
included in our final analyses. All SNPs were in Hardy
Weinberg Equilibrium at the 0.05 level. Linkage disequi-
librium (LD) was assessed using the LDPlotter tool
(https://www.pharmgat.org/Tools/pbtoldplotform).
Measurements of ambient pollution
Ambient PM2.5 and BC were measured hourly at a sta-
tionary monitoring site located at the top of a building
one km from the examination site with a tapered ele-
ment oscillating microbalance (TEOM; model 1400A,
Rupprecht & Pataschnick Co, Albany NY) and aethal-
ometer (Magee Scientific, Berkeley, CA), respectively.
These monitors are operated by the Harvard School of
Public Health and measure urban background pollution.
Daily averages are calculated when at least ¾ the hourly
values for a given day are available. We used seven day
moving averages as our a priori time period of interest
and also examined five and nine day moving averages as
sensitivity analyses. The moving average is the mean
exposure for the immediate time period before each
examination.
SO4
2- was measured using the Harvard/EPA Annular
Denuder System (HEADS) impactors for the time period
1999 - 2002. Sulfur was measured using X-ray fluoures-
cence (XRF) (2003-2008) and converted to SO4
2-. For
days when both HEADS impactors and XRF were in
operation, we confirmed that these two approaches pro-
duced the same results (slope = 1, R2 > 0.9). For days
where duplicate XRF measures were available, we used
the mean of the two measures.
Statistical methods
All statistical analyses were carried out using SAS Ver-
sion 9.2 (SAS Institute, Cary, NC) and R (R Foundation
for Statistical Computing, Vienna, Austria). sICAM-1
and sVCAM-1 measurements were log-transformed to
improve normality in the residuals. We first investigated
the main effects of exposure to PM2.5 on sICAM-1 and
sVCAM-1 levels within the population. BC and SO4
2-
were also assessed to determine whether certain sources
of ambient pollution such as traffic and power plant
emissions produced stronger effects. Our a priori
hypothesis was to examine 7 day moving averages. Ana-
lyses were performed using linear mixed effects models
with random intercepts to account for the correlation
between repeated measures among study participants.
The following potential confounders or predictors of
sICAM-1 and sVCAM-1 were chosen to be included in
the analysis: education (≤12 years, 13-16 years, >16
years), ≥2 servings of alcohol per day (yes/no), age at
first sICAM-1 and sVCAM-1 measurement, time since
first measurement, body mass index (BMI), diabetes
diagnosis or fasting blood sugar >126 mg/dL (yes/no),
smoking status (current, former, never), pack-years
smoked, hypertension medication use (yes/no), statin
use (yes/no), apparent temperature (a measure of per-
ceived temperature) and seasonality using sine and
cosine of month. To better control for infections such
as influenza, we also included a term for high C-reactive
protein (CRP) (>10 mg/L).
We also wanted to determine whether SNPs in
miRNA processing were associated with higher levels of
cellular adhesion molecules. This was done by individu-
ally adding each SNP and its SNP-by-pollutant cross-
product term into the model as specified above. We
then investigated whether there were main effects asso-
ciated with these SNPs.
Multiple testing and false discovery
Multiple testing is a major concern in studies of genetic
epidemiology. However, many standard methods for
computing adjusted p-values and false discovery rates
do not incorporate the correlation that exists in
repeated measures studies. Therefore, we computed
adjusted p-values using a permutation test, which does
not make assumptions about the underlying null distri-
bution of test statistics, and instead uses the data and its
existing correlation within subjects to estimate the
appropriate null distribution. This method avoids mak-
ing strong assumptions about independence of tests that
would be inappropriate for our data.
We briefly describe the permutation method, which
has been widely used in genetic association studies.
First, we fit models of sICAM-1 and sVCAM-1, adjust-
ing for potential confounding variables, and obtained
the observed test statistic for each miRNA SNP. Next,
we fit models of sICAM-1 and sVCAM-1 again, adjust-
ing for potential confounding variables, without includ-
ing the miRNA SNPs, and obtained the residuals. We
then randomly permuted the SNP data and paired each
miRNA profile with a random subject and their residual
(thus retaining the complex correlation structure of the
repeated measures study). We regressed the residuals of
sICAM-1 and sVCAM-1 on this new dataset of random
miRNA-subject profiles. This permutation simulation
was repeated 1000 times. These permuted datasets have
only random genotype-phenotype associations. Thus,
the test statistics from the permuted data represent a
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sample from the distribution of test statistics under the
null hypothesis that there is no effect for any SNP. The
adjusted p-value for each miRNA SNP based on its
observed test statistic was computed as
p− valueadj = #simulations with a permuted test statistic > observed test statistictotal # simulations
Adjusted p-values < 0.05 were considered significant.
Sensitivity analyses
Because all participants did not have the same number
of follow-up visits, and those who had the most may
have been healthier than average, we assessed whether
this differential selection influenced our results. We per-
formed sensitivity analyses restricting to participants
with two or more visits. In addition to testing whether
five and nine day moving averages produced signifi-
cantly different associations, we also examined whether
adjusting for season using dichotomous variables for
Winter, Spring and Summer (treating Fall as the refer-
ent category) altered results. Finally, we performed ana-
lyses excluding current smokers and individuals with
high CRP levels.
Results
Of the 784 Participants in the Normative Aging Study
who provided sICAM-1 and sVCAM-1 measurements,
53 (6.8%) where missing all genotyping. Complete covari-
ate data and all or some of the microRNA-related geno-
typing was available on a total of 723 Normative Aging
Study participants who provided a total of 1652 study
observations. The number of study visits as well as the
clinical characteristics for subjects are described in Table
1. Subjects had between one and five study visits during
the study period where sICAM-1 and sVCAM-1 were
measured. The majority of participants provided two or
three visits. Participants were elderly males, many of
whom were former smokers and had been diagnosed
with hypertension. Fewer visits were available for SO4
2-
analyses because these measures started later and filters
were missing on some days. SO4
2- measures were avail-
able on a subset of days and were matched to a total of
672 NAS participants with 1390 study visits. The clinical
characteristics of participants in this subset were similar
to those with PM2.5 and BC measures available (results
not shown). Table 2 shows the associations for an inter-
quartile range (IQR) change in the seven day moving
averages of PM2.5, BC and SO4
2- and sICAM-1 and
sVCAM-1as well as five and nine day moving averages as
a sensitivity analysis. An IQR change in PM2.5 (4.27 μg/
m3) was associated with 3.1% higher (95%CI: 1.6, 4.6, p <
.001) and 2.5% higher (95%CI: 0.6, 4.5, p=.01) sICAM-1
and sVCAM-1 levels respectively. An IQR change in
SO4
2- (1.39 μg/m3) was associated with 1.4% (95%CI:
Table 1 Mean±, (SD) or study n (%) of Study Participants
at baseline
Population Characteristics mean ± SD or n (%)
Age 72.3 ± 6.9
Systolic blood pressure 133.7 ± 17.3
Diastolic blood pressure 78.1 ± 9.3
Body Mass Index 28.2 ± 4.1
sICAM-1 299.4 ± 101.6
sVCAM-1 1055.2 ± 360.8
Hypertension medication 411 (57)
Statin use 262 (36)
Two or more servings of alcohol per day 147 (20)
CRP > 10 ug/ml 31 (4)
Diabetes Mellitus† 139 (19)
Years of Education ≤12 210 (29)
13-16 349 (48)
>16 164 (23)
smoking status Never 204 (28)
Current 34 (5)
Former 484 (67)
packyrs 22.3 (28)
number of study visits 1 185 (26)
2 205 (28)
3 276 (38)
4 56 (9)
5 1 (<1)
† defined as diagnosis by physician or fasting blood glucose > 126 mg/dL.
Table 2 Percent change in sICAM-1 and sVCAM-1 scaled
to an IQR change in moving average of pollutants
sICAM-1 sVCAM-1
PM2.5† %
change
95% CI P-
value
%
change
95% CI P-
value
7 day 3.1 (1.6, 4.6) <0.001 2.5 (0.6, 4.5) 0.010
5 day 3.0 (1.6, 4.4) <0.001 2.8 (1.0, 4.7) 0.003
9 day 3.4 (2.0, 4.9) <0.001 2.6 (0.7, 4.5) 0.007
SO4*
7 day 1.4 (0.04, 2.7) 0.044 1.6 (-0.4, 3.7) 0.120
5 day 1.7 (0.3, 3.1) 0.017 2.2 (0.2, 4.3) 0.030
9 day 1.3 (0.1, 2.9) 0.071 1.6 (0.5, 3.7) 0.130
BC**
7 day -0.9 (-2.6, 1.0) 0.352 -1.5 (-3.8, 0.8) 0.204
5 day -1.0 (-2.7, 0.7) 0.224 -0.6 (-2.8, 1.7) 0.601
9 day -0.7 (-2.6, 1.3) 0.503 -1.2 (-3.7, 1.3) 0.338
1652 observations from 723 participants included for PM2.5 models. 1390
observations from 672 participants in SO4
2- models.
† 7 day IQR change in PM2.5 = 4.27 μg/m
3
* 7day IQR change in SO4
2- = 1.39 μg/m3
** 7 day IQR change in BC = 0.33 μg/m3
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0.04, 2.7) higher sICAM-1 levels, and a non-statistically
significant change of 1.6% (95%CI: -0.41,3.7) higher
sVCAM-1. BC at this averaging time was not significantly
associated with either measure. Spearman correlations
between PM2.5 and BC, BC and SO4
2-, and PM25 and
SO4
2-were 0.62, 0.55 and 0.80 respectively.
Of the 17 SNPs that were originally genotyped, three
were not included in our analyses because fewer than 10
individuals were homozygous for the minor allele in our
study population (rs417309 in DGCR8, rs197414 in
GEMIN3 and rs3742330 in DICER), leaving a total of 14
SNPs for analysis. All SNPs were in Hardy-Weinberg
Equilibrium at the 0.05 level. The full list of the 14
SNPs included is described in Table 3. Two SNPs had
Hardy Weinberg P-values 0.1 and 0.07 are identified,
but were not excluded.
Our primary analysis of interest was to examine gene-
by-environment interactions between PM2.5 levels and
these SNPs. Because BC was not significantly associated
with sICAM-1 or sVCAM-1, and SO4
2- was missing for
a large number of days in addition to being strongly
correlated with PM2.5, we restricted our analysis of SNP
associations and their interactions to models with PM2.5.
For both sICAM-1 and sVCAM-1, particularly strong
PM-by-SNP interactions were observed with the
rs1062923 GEMIN4 SNP. These results remained signif-
icant after adjustment for multiple testing and are pre-
sented in Table 4. None of the other interactions tested
approached significance (see additional files 1 and 2).
We also examined the main effects of these miRNA
processing SNPs. Although no SNPs met significance cri-
teria for main effects after adjustment for multiple testing
in models predicting ICAM-1, we present results for all
unadjusted associations < 0.1 in Table 5. We found that
one SNP in DICER was associated with 10% higher
sICAM-1 (95%CI: -0.1, 21.1, p = 0.05). Two SNPs in
GEMIN4 that we previously observed to be in high link-
age disequilibrium (Wilker et al. 2010) were associated
with approximately 6% higher sVCAM-1 levels (p = 0.03
and 0.04, unadjusted for multiple testing).
We performed a number of sensitivity analyses to test
the robustness of our results. In our analyses, restricting
to participants with two or more sICAM-1 and
sVCAM-1 did not change our findings. Using indicator
variables for season instead of sine and cosine for
month of year produced similar results. Finally, we
observed that neither restricting to non-smokers, nor
restricting to participants with CRP < 10 mg/dL altered
the results of our pollutant effects for seven day moving
averages of PM2.5.
Discussion
In this repeated measures study of elderly men, we
observed significant associations between seven day
exposures to PM2.5 and both sICAM-1 and sVCAM-1
levels. Additionally, SO4
2- seven day moving averages
were associated with higher levels of sICAM-1 and
sVCAM-1. Results from our sensitivity analyses may
suggest that even longer averaging times are relevant for
PM2.5, particularly in association with sICAM-1. We
also observed evidence of effect modification by a single
SNP involved in the processing of miRNA. Results were
particularly strong for PM interactions with the
rs1062923 SNP in GEMIN4 predicting both adhesion
molecules examined. In both cases, carriers of the var-
iant had lower levels of sICAM-1 and sVCAM-1.
This contrasts with another recent publication from
the Normative Aging Study which examined two day
Table 3 miRNA processing Genes and SNPs included in this study
Gene name Rs number Location Alleles Function Amino Acid Change HWE*≤0.1
Gem-associated protein 3 rs197412 chr1:112110476 T/C Coding exon Isoleucine/Threonine
(GEMIN3)[DDX20] rs197388 chr1:112099005 T/A Promoter
DROSHA[RNASEN] rs10719 chr5:31437204 C/T 3’ UTR
rs6877842 chr5:31568395 C/G promoter
DICER [DICER1] rs13078 chr14:94626500 T/A 3’ UTR
Gem-associated protein 4 rs7813 chr17:594936 T/C Coding exon Cysteine/arginine
[GEMIN4] rs1062923 chr17:595817 T/C Coding exon Isoleucine/Threonine
rs3744741 chr17:595982 C/T Coding exon Arginine Glutamine
rs4968104 chr17:596255 T/A Coding exon Valine/Glutamic acid
rs910925* chr17:596297 G/C Coding exon Glycine/Alanine 0.1
rs2740348 chr17:596685 G/C Coding exon Glutamic acid/Glutamine
rs910924 chr17:602670 C/T Promoter
Digeorge syndrome rs3757* chr22:18479331 A/G 3’ UTR 0.07
critical region gene 8 [ DGCR8] rs1640299 chr22:18478359 G/T 3’ UTR
* Indicates Hardy-Weinberg Equilibrium (HWE) p-value ≤0.1.
Wilker et al. Environmental Health 2011, 10:45
http://www.ehjournal.net/content/10/1/45
Page 5 of 9
moving averages of particles and only observed an asso-
ciation between sICAM-1 and sVCAM-1 with BC [13].
We observed significant associations for sICAM-1 in
our models of seven day moving averages for both
PM2.5 and marginally significant (p = 0.044) results for
SO4
2-. Previous work from our group and others has
suggested that traffic pollution may adversely affect car-
diovascular health and many of these studies have
observed stronger effects with the components of air
pollution associated with traffic particles [8,13]. The
other study we are aware of which examined associa-
tions between sICAM-1 and sVCAM-1 and SO4
2- did so
in a population of diabetics and did not observe a signif-
icant association [3]. However, SO4
2- measures were
only available on a subset of days in that study and the
n for these analyses was small (n = 61). Our results sug-
gest that effects of PM and SO4
2 may be observed over
longer time periods. Despite declines in emissions from
coal-fired fire power plants, our results suggest that
these emissions remain a regulatory concern which may
alter endothelial function.
Data describing the effects of miRNA processing on
cardiovascular processes and inflammation is relatively
limited [27,42]. Even less is known about the role these
processing genes play in interacting with environmental
exposures. The association that we observed for the
rs1062923-PM2.5 cross-product predicting adhesion
molecule level was consistently the strongest of all inter-
actions tested. Carriers of this polymorphism had signif-
icantly lower sICAM-1 and sVCAM-1 responses to
PM2.5 than wild-type and heterozygous individuals. We
recently observed gene-environment interactions
between BC and the rs1062923 SNP in association with
systolic blood pressure [23]. Previously, rs7813, also
located in the GEMIN4 gene, which we observed to be
the associated with higher sVCAM-1 levels in unad-
justed models, was also associated with renal cancer in a
case-control study [39]. Relatively little is known about
the GEMIN4 gene, but it is expressed ubiquitously and
is a part of a large protein complex known as the survi-
val of motor neuron (SMN) complex that participates in
the biogenesis of ribonucleoprotein complexes (RNPs)
in the cytoplasm [43]. The SMN complex then enters
the nucleus with the snRNPs, delivering them to serve
as components of the splicing machinery for miRNA.
The activity of GEMIN4 has also been closely associated
with Galectins 1 and 3 [44]. Galectin 1 is involved in
vascular smooth muscle cell proliferation and Galectin 3
has been associated with diabetic nephropathy [45] and
atherogenesis [46]. Although rs1062923 does induce a
non-synonomous missense mutation from isoleucine to
threonine, it is not known whether it is definitively
functional.
We recognize that our study is subject to a number of
limitations. We have utilized stationary measures of air
pollution to represent personal exposures. Prior research
indicates that when examining longitudinal exposures to
air pollution, most error is of the Berkson type. To the
extent that it is classical, simulation studies have shown
that it is highly unlikely to bias away from the null even in
Table 4 Results for rs1062923-PM2.5 interactions 7 day moving averages†
Endothelial Marker Number of participants % change (95% CI) Unadjusted p-value For interaction Adjusted p-value
sICAM-1 homozygous carriers 31 -9.0 (-15.0, -2.5) 0.0002* 0.004*
Wild-type and heterozygotes 686 3.4 (1.9, 4. 9)
sVCAM-1 homozygous carriers 31 -9.2 (-17.2,-0.5) 0.005 0.1
Wild-type and heterozygotes 686 2.8 (0.9, 4.8)
†IQR change in7 day moving average of PM2.5 = 4.27 μg/m
3
*models adjusted for education (≤12 years, 13-16 years, >16 years), ≥2 alcoholic drinks per day, age at first adhesion molecule measurement, time since first
measurement, body mass index (BMI), diabetes diagnosi or fasting glucose >126 mg/dL, smoking status, pack-years smoked, hypertension medication use (yes/
no), statin use, apparent temperature, seasonality (sine and cosine of month), CRP >10 mg/L.
Table 5 Main effects of SNPs with unadjusted p-value ≤0.1
homozygous carriers/common allele carriers % change 95%CI p-value
sICAM
rs13078 21/677 10.0 (-0.1, 21.1) 0.05
sVCAM-1
rs910925 116/604 6.3 (0.6, 12.3) 0.03
rs7813 116/597 6.1 (0.4, 12.1) 0.04
†unadjusted p-values are reported here. No SNPs identified in main effects analysis were statistically significant at the 0.05 level in models adjusted for multiple
testing. models adjusted for education (≤12 years, 13-16 years, >16 years), ≥2 alcoholic drinks per day, age at first adhesion molecule measurement, time since
first measurement, body mass index (BMI), diabetes or fasting glucose >126 mg/dL, smoking status, pack-years smoked, hypertension medication use (yes/no),
statin use, apparent temperature, seasonality (sine and cosine of month), CRP >10 mg/L.
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the presence of covariates and indicates that this exposure
misclassification may lead to an underestimation of the
health effects of air pollution [47]. In addition, several stu-
dies, including one conducted in the Greater Boston area,
have found that longitudinal measures of ambient particu-
late concentrations are representative of longitudinal var-
iation in personal exposures [48].
Misclassification of the adhesion molecules is possible,
as sICAM-1 and sVCAM-1 were measured in serum,
where it is derived from cleavage and shedding from
endothelial cells, but factors influencing clearance of
these immunologic markers remain uncertain [49]. Addi-
tionally, although ELISA assays for the analysis of
sICAM-1 and sVCAM-1 are subject to variation, the day-
to-day variabilities reported in our study for reference
concentrations were 10% or less and these measures have
previously been associated with cardiovascular disease
[7,49-51]. Variation in findings for sICAM-1 and
sVCAM-1 across studies may also be due to their specific
expression and roles. ICAM-1 is expressed by many cell
types, including endothelial cells, fibroblasts, epithelial
cells, and multiple cells of hematopoietic lineage, while
expression of VCAM-1 mostly occurs on atherosclerotic
plaques and is limited to activation of endothelial and
smooth muscle cells [52]. Varying susceptibilities of
study subjects and differences in time windows studied
may have also contributed to different outcomes; discre-
pant findings may also arise across studies because of dif-
fering sources, composition and mixtures of pollutants.
We also recognize that despite choosing covariates
which we believe to be predictors of our exposure not
on the causal pathway, our results may still be subject
to residual confounding. However, we also included a
random intercept for each subject, which should control
for unmeasured, time-invariant confounders across sub-
jects. Additionally, while this study investigates longer
moving averages than have been previously associated
with acute effects, it is also possible that long-term
exposures may lead to chronic effects which we have
not addressed here.
Finally, we also face the problem of multiple testing.
On the one hand, we are testing a number of associa-
tions and acknowledge the need to be cautious about
identifying false positives. However, we have selected a
pathway driven approach have restricted the number of
tests performed by limiting the associations under study
to recessive models of inheritance. While evidence of
miRNA effects in cardiovascular disease is a rapidly
developing field, we have restricted our analyses to
genes involved in the processing of miRNAs in order to
test these novel hypotheses. Therefore, we report both
our adjusted and unadjusted p-values for this analysis.
Although some of the associations we report did not
meet statistical significance at the more stringent cutoff
value, we believe that the consistency across main effect
and PM2.5 interaction outcomes for SNPs in GEMIN4,
particularly rs1062923, suggests that this particular gene
and its function merit further investigation.
Conclusions
This study provides novel evidence of effect modifica-
tion of the relationship between exposure to particulate
matter and biomarkers of inflammation endothelial
function in a population of elderly community-dwelling
men. It also suggests that air pollution from SO4
2- may
play a role in these processes, especially over longer
averaging times. For the seven day moving averages
examined, strong evidence of effect modification was
found for the rs1062923 SNP in GEMIN4. Our results
suggest that future work investigating epigenetic regula-
tion should consider exposure to ambient pollution as a
potential marker of susceptibility. By examining the
association between such biomarkers and air pollution,
this paper adds to the growing body of evidence that
elevated levels of particulate air pollution may induce
cardiovascular effects through an interrelated process of
inflammation and endothelial dysfunction.
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